top of page
Backgrounds.jpg
Statesman-Examiner Logo 2025 with Shadow.png

Loading...

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MediWound Ltd. - Ordinary Shares (NQ:MDWD)

14.19 -2.49 (-14.93%)
Streaming Delayed Price Updated: 3:53 PM EDT, May 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 374,776
Open 15.80
Bid (Size) 14.18 (9,500)
Ask (Size) 14.29 (200)
Prev. Close 16.68
Today's Range 14.14 - 16.12
52wk Range 14.90 - 22.50
Shares Outstanding 27,272,818
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
MediWound (MDWD) Q1 2026 Earnings Transcript ↗
MediWound (MDWD) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
MediWound Q1 Earnings Call Highlights ↗
MediWound (NASDAQ:MDWD) reported a wider first-quarter loss and lower revenue compared with the prior-year period, while management reaffirmed its 2026 revenue outlook and said it continued to advance... 
Via MarketBeat
Topics Earnings

Performance

YTD
-23.0%
-23.0%
1 Month
-14.4%
-14.4%
3 Month
-19.2%
-19.2%
6 Month
-22.0%
-22.0%
1 Year
-33.4%
-33.4%

More News

Read More
MediWound Ltd. (NASDAQ:MDWD) Q1 2026: Revenue Miss but Narrower Loss, Full-Year Outlook Intact ↗
Via Chartmill
News headline image
MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
From MediWound Ltd.
Via GlobeNewswire
MediWound Ltd. (NASDAQ:MDWD) Reports Q4 2025 Revenue Miss Despite Pipeline Progress ↗
Via Chartmill
News headline image
MediWound to Report First Quarter 2026 Financial Results
From MediWound Ltd.
Via GlobeNewswire
News headline image
Newly Published U.S. Expert Consensus Aligns with MediWound’s Strategy for Chronic Wound Debridement
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound to Present New EscharEx® Data at Leading Wound Care Conferences
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Files Annual Report on Form 20-F
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound (MDWD) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
MediWound Reports Fourth Quarter and Full Year 2025 Financial Results
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound to Report Fourth Quarter and Full Year 2025 Financial Results
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound to Present at Upcoming Investor Conferences
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Ltd (NASDAQ:MDWD) Reports Q3 2025 Earnings: Revenue Misses, EPS Beats Estimates ↗
Via Chartmill
News headline image
MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update
From MediWound Ltd.
Via GlobeNewswire
News headline image
Examining the Future: MediWound's Earnings Outlook ↗
Via Benzinga
News headline image
MediWound to Report Third Quarter 2025 Financial Results
From MediWound Ltd.
Via GlobeNewswire
News headline image
Earnings Scheduled For November 20, 2025 ↗
Via Benzinga
News headline image
MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound’s NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress
From MediWound Ltd.
Via GlobeNewswire

Frequently Asked Questions

Is MediWound Ltd. - Ordinary Shares publicly traded?
Yes, MediWound Ltd. - Ordinary Shares is publicly traded.
What exchange does MediWound Ltd. - Ordinary Shares trade on?
MediWound Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for MediWound Ltd. - Ordinary Shares?
The ticker symbol for MediWound Ltd. - Ordinary Shares is MDWD on the Nasdaq Stock Market
What is the current price of MediWound Ltd. - Ordinary Shares?
The current price of MediWound Ltd. - Ordinary Shares is 14.19
When was MediWound Ltd. - Ordinary Shares last traded?
The last trade of MediWound Ltd. - Ordinary Shares was at 05/27/26 03:53 PM ET
What is the market capitalization of MediWound Ltd. - Ordinary Shares?
The market capitalization of MediWound Ltd. - Ordinary Shares is 387.00M
How many shares of MediWound Ltd. - Ordinary Shares are outstanding?
MediWound Ltd. - Ordinary Shares has 387M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page